SLGL

Sol-Gel Technologies Ltd.

Price

$62.41

return (12m)

104.62%

p/e

-7.33

p/bv

3.97

DIVIDEND YIELD

0.00%

SLGL price

Sol-Gel Technologies

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment SLGL

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-21.52%

3 months

-16.44%

1 year

104.62%

2 years

788.65%

5 years

-29.48%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals SLGL

Valuation

P/E

-7.33

Sector 1.09

Industry -1.78

P/BV

3.97

Sector 1.86

Industry 1.35

P/Revenue (PSR)

82.75

Sector 1.55

Industry 2.25

EV/EBITDA

-34.31

Sector -47.62

Industry -42.38

EV/EBIT

-34.31

Sector -27.52

Industry -45.58

P/EBITDA

-10.76

Sector -32.64

Industry -23.10

P/EBIT

-10.76

Sector -43.02

Industry -27.18

P/Total Assets

3.55

Sector 0.87

Industry 0.82

P/Net Current Assets

4.20

Sector -27.09

Industry -72.46

P/Working Capital

4.13

Sector -4.05

Industry -2.10

EPS

-8.51

Sector -0.70

Industry -1.11

BVPS

15.74

Sector 4.34

Industry 2.54

Efficiency

Gross Margin

100.00%

Sector 49.36%

Industry 50.48%

EBITDA Margin

-595.42%

Sector -283.40%

Industry -17,123,193.33%

EBIT Margin

-595.42%

Sector -164.84%

Industry -17,075,660.18%

Operating Margin

-100.00%

Sector -19.73%

Industry -25.75%

Net Profit Margins

-100.00%

Sector -24.22%

Industry -27.82%

Asset Turnover

0.01

Sector 0.13

Industry 0.06

Profitability

ROE

-54.07%

Sector -24.32%

Industry -33.33%

ROA

-48.38%

Sector -24.41%

Industry -45.72%

ROIC

-517.02%

Sector -529.97%

Industry -855.00%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

10.37

Sector 1.90

Industry 2.51

Net Debt / EBITDA

11.52

Sector -4.96

Industry -8.98

Net Debt / EBIT

11.52

Sector -3.08

Industry -37.38

Net Debt / Equity

-1.00

Sector -0.45

Industry -1.16

Gross Debt / Equity

0.00

Sector -0.74

Industry -0.56

Equity/Assets

0.89

Sector 0.46

Industry 0.52

Liabilities/Assets

0.11

Sector 0.49

Industry 0.47

Growth

5Y Revenue CAGR

-43.72%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals SLGL

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
SLGL Sol-Gel Technologies Ltd.	$62.41	156.30%	0.00%	-7.33	3.97	-54.07%	-100.00%
LLY Eli Lilly and Compay	$1,142.35	51.23%	0.59%	38.16	30.09	78.84%	33.53%
SNY Sanofi	$42.38	-6.23%	4.17%	3.97	0.73	18.43%	14.25%
GSK GlaxoSmithKline PLC	$50.03	29.66%	3.54%	15.39	4.35	28.24%	14.54%
CRMD CorMedix Inc.	$7.69	-30.85%	0.00%	3.22	1.31	40.62%	40.49%
AMPH Amphastar Pharmaceuticals Inc.	$23.73	-12.06%	0.00%	13.18	1.35	10.23%	10.76%
RDY Dr. Reddy's Laboratories Ltd.	$12.16	-17.58%	0.69%	27.59	2.49	9.03%	10.14%
ENLV Enlivex Therapeutics Ltd.	$0.78	-95.06%	0.00%	0.01	0.01	63.85%	0.00%
ISRG Intuitive Surgical Inc.	$392.49	-9.49%	0.00%	44.01	7.60	17.26%	28.62%
NVS Novartis AG	$139.78	16.35%	2.22%	20.89	6.35	30.39%	23.28%
TMO Thermo Fisher Scientific Inc.	$653.75	38.92%	0.28%	34.71	4.60	13.25%	15.07%
ABT Abbott Laboratories	$102.63	-21.99%	2.25%	35.46	3.76	10.61%	11.65%
MDT Medtronic PLC	$92.33	1.59%	3.11%	22.28	2.31	10.35%	14.02%
BSX Boston Scientific Corp.	$43.52	-55.82%	0.00%	17.60	2.59	14.73%	17.49%
TMDX TransMedics Group Inc.	$87.47	-27.00%	0.00%	19.94	5.84	29.28%	22.69%
RMD ResMed Inc.	$227.07	-15.55%	0.80%	21.51	4.98	23.13%	26.94%
IDXX IDEXX Laboratories Inc.	$512.11	-20.09%	0.00%	35.48	25.07	70.67%	25.03%
HCA HCA Healthcare Inc.	$429.56	8.26%	0.70%	12.06	-29.52	-244.72%	10.07%
COHR Coherent Inc.	$308.78	198.60%	0.00%	75.62	5.36	7.09%	11.19%
DHR Danaher Corporation	$211.66	9.40%	0.68%	37.21	2.83	7.61%	15.95%
SYK Stryker Corp.	$276.81	-25.56%	1.26%	28.38	4.41	15.55%	14.43%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

SLGL Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Sol-Gel Technologies

Sol-Gel Technologies Ltd.

Average Investor10 user rating

4.0 (1 people)

United States

29 years

Founded: 1997

2018

Time since IPO - 8 years

61

Employees

Sol-Gel Technologies Ltd. (United States) is listed on the Nasdaq and has a market capitalization of $190.73 million, with shareholders equity totaling $48.10 million.

The company employs approximately 61 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, Sol-Gel Technologies Ltd. reported $2.31 million in revenue, generating net income of $-26.01 million.

Key financial metrics include a P/E ratio of -7.33, a price-to-book (P/B) ratio of 3.97, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker SLGL.

Market cap

$190.73 million

Net worth

$48.10 million

$48,096,000.00

Assets

$53.76 million

$53,756,000.00

Total Shares Outstanding

3.06 million

3,056,000

Average Daily Trading Volume

$58.63 Thousand

$58,630.00

Sector

Health

Industry

Pharmaceutical Products

SLGL

SLGL revenue and profits

Financial Results SLGL

DRAG THE FRAME TO SEE MORE DATA

SLGL cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$88.45 21,79% (12M)

P/E

-0.79

3.01%

ROE

-178.93%

P/BV

1.42

CI - Cigna

$275.31 --3,58% (12M)

P/E

10.57

1.69%

ROE

16.04%

P/BV

1.70

CNC - Centene

$65.99 107,71% (12M)

P/E

-6.38

0.00%

ROE

-22.56%

P/BV

1.44

HUM - Humana

$384.07 54,21% (12M)

P/E

35.53

0.93%

ROE

6.72%

P/BV

2.39

SNY - Sanofi

$42.38 --7,54% (12M)

P/E

3.97

4.17%

ROE

18.43%

P/BV

0.73

LLY - Eli Lilly

$1,142.35 52,87% (12M)

P/E

38.16

0.59%

ROE

78.84%

P/BV

30.09

HCA - HCA Healthcare

$429.56 7,48% (12M)

P/E

12.06

0.70%

ROE

-244.72%

P/BV

-29.52

NVS - Novartis

$139.78 15,92% (12M)

P/E

20.89

2.22%

ROE

30.39%

P/BV

6.35